Therefore, stroke, encephalitis, posterior reversible encephalopathy, mononeuropathy and polyneuropathy, and Behçet’s disease-like presentations should prompt healthcare professionals to consider excluding ADA2 deficiency, especially, but not only in childhood. This evidence concerns the gene ADA2 and Stroke.